Palmitoylation of the human β2-adrenergic receptor

Brian F. O’Dowd(Duke Medical Center), Mark Hnatowich(Howard Hughes Medical Institute), Marc G. Caron(Duke University Hospital), Robert J. Lefkowitz(Duke University Hospital), Michel Bouvier(Howard Hughes Medical Institute)
Journal of Biological Chemistry
May 1, 1989
Cited by 599Open Access
Full Text

Abstract

We report that a cysteine residue in the human beta 2-adrenergic receptor (beta 2AR) is covalently modified by thioesterification with palmitic acid. By site-directed mutagenesis of the receptor, we have identified Cys341 in the carboxyl tail of the protein as the most likely site of palmitoylation. Mutation of Cys341 to glycine results in a nonpalmitoylated form of the receptor that exhibits a drastically reduced ability to mediate isoproterenol stimulation of adenylyl cyclase. The functional impairment of this mutated beta 2AR is also reflected in a markedly reduced ability to form a guanyl nucleotide-sensitive high affinity state for agonists, characteristic of wild-type receptor. These results indicate that post-translational modification by palmitate of beta 2AR may play a crucial role in the normal coupling of the receptor to the adenylyl cyclase signal transduction system.


Related Papers

No related papers found

Powered by citation graph analysis